This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2002 Feb 16;359(9306):540-1.

doi: 10.1016/S0140-6736(02)07718-8.

Adverse reactions to TNF-alpha inhibitors in rheumatoid arthritis

Affiliations

PMID: 11867103
DOI: 10.1016/S0140-6736(02)07718-8

Comment

Adverse reactions to TNF-alpha inhibitors in rheumatoid arthritis

Richard Day. Lancet. 2002.

. 2002 Feb 16;359(9306):540-1.

doi: 10.1016/S0140-6736(02)07718-8.

Author

Affiliation

¹ Department of Clinical Pharmacology and Toxicology, St Vincent's Hospital, University of New South Wales, 2010, Sydney, Australia. r.day@unsw.edu.au

PMID: 11867103
DOI: 10.1016/S0140-6736(02)07718-8

No abstract available

PubMed Disclaimer

Comment on

Drug-induced systemic lupus erythematosus associated with etanercept therapy.
Shakoor N, Michalska M, Harris CA, Block JA. Shakoor N, et al. Lancet. 2002 Feb 16;359(9306):579-80. doi: 10.1016/S0140-6736(02)07714-0. Lancet. 2002. PMID: 11867114

Similar articles

Perforating folliculitis associated with tumour necrosis factor-alpha inhibitors administered for rheumatoid arthritis.
Gilaberte Y, Coscojuela C, Vázquez C, Roselló R, Vera J. Gilaberte Y, et al. Br J Dermatol. 2007 Feb;156(2):368-71. doi: 10.1111/j.1365-2133.2006.07598.x. Br J Dermatol. 2007. PMID: 17223880 Review.
Anti-tumor necrosis factor alpha switching in rheumatoid arthritis and juvenile chronic arthritis.
Favalli EG, Arreghini M, Arnoldi C, Panni B, Marchesoni A, Tosi S, Pontikaki I. Favalli EG, et al. Arthritis Rheum. 2004 Apr 15;51(2):301-2. doi: 10.1002/art.20242. Arthritis Rheum. 2004. PMID: 15077278 Clinical Trial. No abstract available.
Unstable diabetes in a patient receiving anti-TNF-alpha for rheumatoid arthritis.
Boulton JG, Bourne JT. Boulton JG, et al. Rheumatology (Oxford). 2007 Jan;46(1):178-9. doi: 10.1093/rheumatology/kel322. Epub 2006 Sep 23. Rheumatology (Oxford). 2007. PMID: 16998233 No abstract available.
Anti-TNF-alpha therapies: they are all the same (aren't they?).
Mpofu S, Fatima F, Moots RJ. Mpofu S, et al. Rheumatology (Oxford). 2005 Mar;44(3):271-3. doi: 10.1093/rheumatology/keh483. Epub 2004 Nov 23. Rheumatology (Oxford). 2005. PMID: 15561736 Review. No abstract available.
[TNFalpha inhibitors for the treatment of rheumatoid arthritis].
Sany J, Kaiser MJ. Sany J, et al. Ann Med Interne (Paris). 2002 Feb;153(1):34-40. Ann Med Interne (Paris). 2002. PMID: 11994688 Review. French.

See all similar articles

Cited by

Modelling the time to onset of adverse reactions with parametric survival distributions: a potential approach to signal detection and evaluation.
Maignen F, Hauben M, Tsintis P. Maignen F, et al. Drug Saf. 2010 May 1;33(5):417-34. doi: 10.2165/11532850-000000000-00000. Drug Saf. 2010. PMID: 20397741
Inflammation-Triggered Supramolecular Nanoplatform for Local Dynamic Dependent Imaging-Guided Therapy of Rheumatoid Arthritis.
Li L, Wang X, Gao R, Zhang B, Liu Y, Zhou J, Fu L, Wang J. Li L, et al. Adv Sci (Weinh). 2022 Mar;9(7):e2105188. doi: 10.1002/advs.202105188. Epub 2022 Jan 12. Adv Sci (Weinh). 2022. PMID: 35023331 Free PMC article.
Abatacept (cytotoxic T lymphocyte antigen 4-immunoglobulin) improves B cell function and regulatory T cell inhibitory capacity in rheumatoid arthritis patients non-responding to anti-tumour necrosis factor-α agents.
Picchianti Diamanti A, Rosado MM, Scarsella M, Germano V, Giorda E, Cascioli S, Laganà B, D'Amelio R, Carsetti R. Picchianti Diamanti A, et al. Clin Exp Immunol. 2014 Sep;177(3):630-40. doi: 10.1111/cei.12367. Clin Exp Immunol. 2014. PMID: 24773026 Free PMC article.
Antiphospholipid antibodies during 6-month treatment with infliximab: a preliminary report.
Kolarz B, Majdan M, Darmochwal-Kolarz DA, Dryglewska M. Kolarz B, et al. Med Sci Monit. 2014 Jul 16;20:1227-31. doi: 10.12659/MSM.890270. Med Sci Monit. 2014. PMID: 25027437 Free PMC article.
Therapeutic Benefit in Rheumatoid Cachexia Illustrated Using a Novel Primary Human Triple Cell Coculture Model.
Ollewagen T, Tarr GS, Myburgh KH, Reuter H, Smith C. Ollewagen T, et al. Int J Inflam. 2022 Jun 2;2022:1524913. doi: 10.1155/2022/1524913. eCollection 2022. Int J Inflam. 2022. PMID: 35693848 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information